Reuters logo
BRIEF-Foamix announces completion of patient enrollment in phase 3 acne trials for Minocycline Foam FMX101
November 28, 2016 / 1:47 PM / a year ago

BRIEF-Foamix announces completion of patient enrollment in phase 3 acne trials for Minocycline Foam FMX101

Nov 28 (Reuters) - Foamix Pharmaceuticals Ltd -

* Foamix announces completion of patient enrollment in phase 3 acne trials for Minocycline Foam FMX101

* Foamix Pharmaceuticals is conducting two phase 3 pivotal trials simultaneously, and expects to report top-line results in first half of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below